AI assistant
HEALIUS LIMITED — Director's Dealing 2018
Sep 17, 2018
65058_rns_2018-09-17_54f22a6f-d7a8-4b9d-aab9-15a0dce5a57a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Introduced 30/09/01 Amended 01/01/11 | |
|---|---|
| Name of entity | PRIMARY HEALTH CARE LIMITED |
| ABN | 24 064 530 516 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Arlene Tansey |
|---|---|
| Date of last notice | 7 June 2013 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to therelevantinterest. | As shown |
| Date of change | 14 September 2018 |
| No. of securities held prior tochange | 10,000 Ordinary sharesMantan Nominees Pty Ltd<Mantan Super Fund A/C> |
| Class | Fully paid ordinary shares |
| Number acquired | 1,920 |
| Number disposed | Not applicable |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation | $2.50 per share |
| No. of securities held afterchange | 11,920 Ordinary sharesMantan Nominees Pty Ltd<Mantan Super Fund A/C> |
| Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back | Issue of share entitlement under Accelerated Non-Renounceable Pro Rata Entitlement Offer |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts Not applicable
Part 3 –[+] Closed period
| ’ | ’ |
|---|---|
| Part 2 – Change of directors interests in contractsNot applicablePart 3 –+Closed period | |
| Were the interests in the securities or contractsdetailed above traded during a+closed period where**prior written clearance was required? ** | Not applicable |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | Not applicable |
| If prior written clearance was provided, on what datewas this provided? | Not applicable |
Charles Tilley Company Secretary Date: 18 September 2018
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011